生命科学资讯

The Bull Case For Illumina (ILMN) Could Change Following Its Billion Cell Atlas Pharma Alliance - Yahoo Finance Singapore

Identification of a sub-population of synovial mesenchymal stem cells with enhanced treatment efficacy in a rat model of osteoarthritis

Single-cell profiling of trabecular meshwork identifies mitochondrial dysfunction in a glaucoma model that is protected by vitamin B3 treatment

Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity

Nanoparticles hijack calvarial immune cells for CNS drug delivery and stroke therapy

Continuum architecture dynamics of vesicle tethering in exocytosis

Multimodal supramolecular targeting chimeras enable spatiotemporally resolved protein degradation in vivo

ImmunityBio's cell therapy posts encouraging early data in rare blood cancer

Scientists turn cells’ most mysterious structures into spies on genetic activity

Your Media Choice Might Be Designing Your T-Cell Fate

EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation

Myelin antigen capture in the CNS by B cells expressing EBV latent membrane protein 1 leads to demyelinating lesion formation

Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis

JPM26: Paying cash for obesity drugs, renewed IPO optimism and pharma’s cell therapy view

Illumina unveils massive cell atlas to speed up drug discovery - San Diego Union-Tribune

Afadin sorts different retinal neuron types into accurate cellular layers

JPM26: Illumina debuts Billion Cell Atlas to drive AI-driven drug discovery - Pharmaceutical Technology

Oricell raises $70M series C to advance China-developed CAR Ts

Cell/gene therapy sector now sustainable; China competition mounting

Illumina Introduces Illumina Billion Cell Atlas To Accelerate AI Drug Discovery - Nasdaq